Dr. Schwerkoske is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6025 Lake Rd
Ste 110
Woodbury, MN 55125Phone+1 651-735-7414Fax+1 651-735-1827
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 1982 - 1984
Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 1981 - 1982- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1978 - 1981
Ohio State University College of MedicineClass of 1978
Certifications & Licensure
MN State Medical License 1991 - 2025
MO State Medical License 1982 - 2024
OH State Medical License 1978 - 2024
TN State Medical License 1984 - 2024
MS State Medical License 1987 - 2023
WI State Medical License 1995 - 2023- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- 43 citationsPhase 1/2 trial of temsirolimus and sorafenib in the treatment of patients with recurrent glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572David Schiff, Kurt A. Jaeckle, S. Keith Anderson, Evanthia Galanis, Caterina Giannini
Cancer. 2018-04-01 - 2 citationsA phase II open-label trial of bortezomib in patients with multiple myeloma who have undergone an autologous peripheral blood stem cell transplant and failed to achiev...Robert M. Rifkin, Andrew Greenspan, John F. Schwerkoske, Romeo A. Mandanas, Joe Stephenson
Investigational New Drugs. 2012-04-01 - 155 citationsPhase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study.Bret Edward Buckley Friday, S. Keith Anderson, Jan C. Buckner, Chunrong Yu, Caterina Giannini
Neuro-Oncology. 2012-02-01
Press Mentions
BCBS Minnesota, Minnesota Oncology Achieve 10% Cost Reduction Through Value-Based ContractDecember 23rd, 2022- Blue Cross and Blue Shield of Minnesota and Minnesota Oncology Provide Preliminary Results on Value Based AgreementDecember 16th, 2022
- Minnesota Oncology Joins Mayo Clinic Care NetworkDecember 10th, 2020
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
